January 15, 2018 (Vol. 38, No. 2)

SpeeDx

The PlexPCR® VHS multiplex qPCR test offers a single-well solution to cover the detection and differentiation of the main causes of genital and oral lesions: herpes simplex virus types 1 and 2 (HSV-1, HSV-2), Treponema pallidum (syphilis), and varicella zoster virus (VZV). Validated for use on multiple lesion specimen types, the test is designed to streamline workflows and support rapid, appropriate clinical management of infections with similar symptoms. The SpeeDx portfolio is based on advanced multiplex technology, and the PlexPCR VHS test is the latest to gain CE-IVD mark, supplementing the company’s range of market-leading infectious disease and antibiotic resistance detection tests. 

Previous articleTumor-Related Immune Checkpoints And The Development Of Targeted Cancer Immunotherapies
Next articleTop 10 Best-Selling Cancer Drugs, Q1–Q3 2017